Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Maiorino

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Endocrinological Investigation|June 4, 2020
Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?G Bellastella, M I Maiorino, K Esposito
Journal of Endocrinological Investigation|October 22, 2021
Reply to the letter to the editor by Mungmunpuntipantip et alM Longo, M I Maiorino, K Esposito
Journal of Endocrinological Investigation|March 18, 2018
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndromeM I Maiorino, G Bellastella, D Giugliano, et al.
Journal of Endocrinological Investigation|April 29, 2018
Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialogD Giugliano, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|October 7, 2018
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetesD Giugliano, M I Maiorino, G Bellastella, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 2, 2009
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitusK Esposito, M I Maiorino, C Di Palo, et al.
Journal of Endocrinological Investigation|April 8, 2019
Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysisD Giugliano, P Chiodini, M I Maiorino, et al.
Diabetes, Obesity & Metabolism|October 1, 2011
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patientsK Esposito, P Chiodini, G Bellastella, et al.
International Journal of Impotence Research|April 9, 2010
Determinants of female sexual dysfunction in type 2 diabetesK Esposito, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|September 11, 2016
Sexual function in young women with type 1 diabetes: the METRO studyM I Maiorino, G Bellastella, F Castaldo, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Endocrinological Investigation|June 4, 2020
Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?G Bellastella, M I Maiorino, K Esposito
Journal of Endocrinological Investigation|October 22, 2021
Reply to the letter to the editor by Mungmunpuntipantip et alM Longo, M I Maiorino, K Esposito
Journal of Endocrinological Investigation|March 18, 2018
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndromeM I Maiorino, G Bellastella, D Giugliano, et al.
Journal of Endocrinological Investigation|April 29, 2018
Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialogD Giugliano, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|October 7, 2018
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetesD Giugliano, M I Maiorino, G Bellastella, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 2, 2009
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitusK Esposito, M I Maiorino, C Di Palo, et al.
Journal of Endocrinological Investigation|April 8, 2019
Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysisD Giugliano, P Chiodini, M I Maiorino, et al.
Diabetes, Obesity & Metabolism|October 1, 2011
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patientsK Esposito, P Chiodini, G Bellastella, et al.
International Journal of Impotence Research|April 9, 2010
Determinants of female sexual dysfunction in type 2 diabetesK Esposito, M I Maiorino, G Bellastella, et al.
Journal of Endocrinological Investigation|September 11, 2016
Sexual function in young women with type 1 diabetes: the METRO studyM I Maiorino, G Bellastella, F Castaldo, et al.
Pageof 4